Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia.
Pepeler MS, Tıglıoglu M, Dagdas S, Ozhamamcıoglu E, Han U, Albayrak A, Aydın MS, Korkmaz G, Pamukcuoğlu M, Ceran F, Albayrak M, Ozet G. Pepeler MS, et al. Among authors: ozet g. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e161-e167. doi: 10.1016/j.clml.2023.12.015. Epub 2024 Jan 17. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38342726
Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF.
Demirer T, Ayli M, Ozcan M, Gunel N, Haznedar R, Dagli M, Fen T, Genc Y, Dincer S, Arslan O, Gürman G, Demirer S, Ozet G, Uysal A, Konuk N, Ilhan O, Koc H, Akan H. Demirer T, et al. Among authors: ozet g. Br J Haematol. 2002 Feb;116(2):468-74. doi: 10.1046/j.1365-2141.2002.03264.x. Br J Haematol. 2002. PMID: 11841454 Free article. Clinical Trial.
Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation.
Demirer T, Ayli M, Dagli M, Haznedar R, Genc Y, Fen T, Dincer S, Unal E, Gunel N, Seyrek E, Ustun T, Ustael N, Yildiz M, Sertkaya D, Ozet G, Muftuoglu O. Demirer T, et al. Among authors: ozet g. Br J Haematol. 2002 Sep;118(4):1104-11. doi: 10.1046/j.1365-2141.2002.03762.x. Br J Haematol. 2002. PMID: 12199792 Free article.
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. Demirer T, et al. Among authors: ozet g. Bone Marrow Transplant. 2003 May;31(9):755-61. doi: 10.1038/sj.bmt.1703918. Bone Marrow Transplant. 2003. PMID: 12732881
Expression of IFITM1 in chronic myeloid leukemia patients.
Akyerli CB, Beksac M, Holko M, Frevel M, Dalva K, Ozbek U, Soydan E, Ozcan M, Ozet G, Ilhan O, Gürman G, Akan H, Williams BR, Ozçelik T. Akyerli CB, et al. Among authors: ozet g. Leuk Res. 2005 Mar;29(3):283-6. doi: 10.1016/j.leukres.2004.07.007. Leuk Res. 2005. PMID: 15661263 Free article.
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Beksac M, Haznedar R, Firatli-Tuglular T, Ozdogu H, Aydogdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Beksac M, et al. Among authors: ozet g. Eur J Haematol. 2011 Jan;86(1):16-22. doi: 10.1111/j.1600-0609.2010.01524.x. Epub 2010 Nov 22. Eur J Haematol. 2011. PMID: 20942865 Clinical Trial.
94 results